Genmab A/S (4 jobannoncer)
Genmab is a leading international biotechnology company that aims to improve the lives of patients by creating and developing innovative antibody products. The company was founded in Copenhagen, Denmark in 1999. Genmab’s ordinary shares are publicly traded on Nasdaq Copenhagen and American Depositary Shares under its ADR Program are listed in the United States on the Nasdaq Global Select Market. Genmab employs approximately 478 people at its core facilities in Denmark, the Netherlands and the United States. In addition Genmab has a regional office in Japan.